Mesalamine 800 mg delayed-release tablets, referencing ASACOL HD ® - Lenalidomide capsules, referencing REVLIMID ® BRIDGEWATER, N.J., February 19, 2025--(BUSINESS WIRE)--Amnea ...

Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment ...

today announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment of moderately active ulcerative colitis in adults. Additionally, the Company ...

announced the launch of its mesalamine 800 mg delayed-release tablets for treating moderately active ulcerative colitis in adults. InvestingPro analysis suggests the stock is currently fairly ...

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation ("Twist" or the "Company"), a core mid-cap growth and value equity company in the life sciences segment of the health ...

announced the launch of its mesalamine 800 mg delayed-release tablets for treating moderately active ulcerative colitis in adults. InvestingPro analysis suggests the stock is currently fairly valued, ...

If you're looking for a larger canvas for reading, sketching, gaming, or just about anything else, you're likely much better off going with a tablet. This lets your smartphone keep doing what it ...

If you want a great Android tablet, you should be shopping for Samsung. My team and I review dozens of tablets every year, and I think Samsung reliably makes some of the best Android slates on the ...